Chemistry Hougang: How Medicines Work

A medicine looks ordinary once it reaches a shelf: a labelled box, a tablet, a liquid or an injection in a clinic. But the science behind it is astonishing. Someone must identify a useful biological target, discover or design a candidate, learn how it behaves in the body, make it reproducibly and test whether its benefits justify its risks. No single molecular diagram can do all of those jobs.

In this Chemistry Hougang guide, I want to answer two common questions: how do medicines work? and how does Chemistry lead from a Secondary Science classroom to medicinal chemistry and drug discovery? Students may arrive while looking for a Chemistry tutor in Hougang, help with Secondary Chemistry or JC H2 Chemistry, but the larger prize is understanding how careful chemical reasoning eventually serves people.

When a learner memorises a formula, I ask them what the atoms, bonds and charges represent. When the learner studies medicines, I ask an additional question: which parts of the claim have been established in cells, in animals or in people? The difference matters. A plausible molecular mechanism is the beginning of drug development, not proof of a successful treatment.

What is the difference between a chemical substance and a medicine?

A chemical substance can have a defined composition or molecular structure. A medicine is a product used for a specific medical purpose, developed and regulated in a particular form, strength and context. Its active ingredient is only one part of the full story; formulation, manufacturing consistency, quality controls, packaging, clinical evidence and appropriate use matter too.

A medicine may contain a small synthetic molecule or a larger biological product such as a protein. Some products act by binding enzymes, receptors or ion channels; others work through different physiological, chemical or physical mechanisms. It would be inaccurate to claim that all medicines operate through exactly one “lock and key” interaction.

In Singapore, the Health Sciences Authority explains that therapeutic products require scientific evaluation of quality, safety and efficacy. The terminology and detailed regulation differ around the world. In the United States, the FDA describes discovery, preclinical testing, clinical research, regulatory review and post-market monitoring.

I want students to notice the shared principle rather than assume every country has an identical approval process. A medicine is not established as safe and effective merely because someone can draw its structure or measure activity in a test tube.

First, understand the molecule

Think of a molecule as a three-dimensional arrangement of atoms joined by chemical bonds. Two substances can contain the same types and numbers of atoms yet have different connectivity or spatial arrangements. They may therefore exhibit different physical properties and interact differently with biological systems.

That is why structural isomerism and, at more advanced levels, stereochemistry, matter. A molecular formula alone may not uniquely identify a structure. Molecular shape, charge distribution, hydrogen-bonding capabilities, flexibility and other features affect how a compound behaves.

A Secondary student begins with formulae, covalent bonding and functional groups. A JC student may study organic reactions, acidity, nucleophiles, stereochemistry and equilibria according to their course. A university medicinal chemist may investigate conformations, binding interactions, solubility, metabolism, transport and selectivity. Each step grows from the previous one rather than replacing it.

Why a tiny structural change can matter

Imagine two fictitious candidate molecules, A and B, that have related structures but one different functional group. That change may alter the molecule’s polarity, ionisation, solubility, binding pattern or rate of metabolic breakdown. It might improve a useful property while worsening another. We cannot establish the outcome from a drawing alone.

A student who simply says “B is better because it has more hydrogen bonds” is guessing. Hydrogen bonding can matter, but favourable interactions depend on the molecule’s surroundings, geometry, competition with water and broader thermodynamics. Strong binding is not automatically the same as better clinical performance.

I teach a useful sentence frame: Changing [specific structural feature] could influence [particular property] because [chemical mechanism]; this needs to be tested by [appropriate measurement]. It encourages informed prediction without false certainty.

The molecule must reach the right place

Once a potential active substance is identified, it must be delivered in a workable way. For many medicines, formulation influences stability, dissolution, release and delivery. Route of administration matters: an oral tablet, an inhaled drug and an injected medicine encounter different barriers and conditions.

In a simplified oral example, a solid ingredient needs to become available in solution before it can cross relevant biological barriers. But dissolution is not the same as absorption; absorption is not the same as reaching the site of action; and reaching the site is not the same as producing clinical benefit.

These distinctions belong to pharmacokinetics and pharmacodynamics. Pharmacokinetics examines how exposure changes over time through absorption, distribution, metabolism and excretion. Pharmacodynamics examines what the substance does to the biological system, including useful and unwanted effects.

They are connected, not interchangeable. A beautifully designed molecule can fail as a medicine if it is unstable, cannot reach the appropriate tissue, is cleared too rapidly, causes unacceptable toxicity or has no meaningful patient benefit.

Acid–base chemistry makes medicines more interesting

A great many molecules contain functional groups that can gain or lose protons. Their ionisation states can depend on the pH of the surrounding environment. That affects electrostatic interactions, solubility and potentially transport, although real biological systems are far more complex than one equilibrium equation.

At Secondary level, I teach what it means for an acid to donate H⁺ under an appropriate model and how ions differ from neutral molecules. At JC level, students can use pKa, Ka and pH to discuss weak-acid equilibria.

For a fictional, idealised monoprotic acid HA, the equilibrium HA ⇌ H⁺ + A⁻ leads to the relation pH = pKa + log₁₀([A⁻]/[HA]) under the usual dilute-solution approximations.

Suppose pKa = 5.0. At pH 5.0, the simplified equilibrium predicts [A⁻]/[HA] = 1, so the concentrations are equal. At pH 6.0, that ratio becomes 10, meaning the ionised form’s concentration is ten times the neutral form’s concentration in this simplified system.

The lesson is about chemical reasoning, not about changing how anyone takes medication. Real drug formulations, biological compartments, protein binding and transport are complex. Medication instructions must come from the appropriate healthcare professional and authorised product information, not from a student’s pKa exercise.

Drug discovery does not begin with one perfect answer

One possible research route begins with identifying a biological target connected to a disease process. Researchers then look for candidates that interact with that target and perform experiments to characterise them. Candidates may arise from screening compounds, rational design, biological research or unexpected findings.

A promising early result generates questions rather than closing them. Was the observation reproducible? Is the result specific to the intended target? Was the assay affected by impurities, fluorescence, solvent conditions or other interference? Is the biological effect meaningful in an appropriate model? Could the candidate have unwanted effects elsewhere?

The US National Institutes of Health outlines the complexity of moving an investigational drug from discovery to clinical development. Many candidates do not progress successfully. It is a mistake to treat every published laboratory result as the announcement of a medicine people can already use.

I want students to be comfortable with that uncertainty. A scientist can learn a great deal from a failed candidate by understanding which prediction did not survive testing.

How a candidate becomes a reproducible product

After discovery comes the difficult task of making material of suitable quality. Chemists may need to control reaction conditions, impurity profiles, stability, solvents, crystal forms and process reproducibility. The desired molecular structure must be established, and the material’s composition and impurities must be measured with suitable methods.

A synthesis that works once in a small flask may not be appropriate for manufacturing at a very different scale. Mixing, heat transfer, reaction rates, raw materials, safety and purification can all change what is practical. A process chemist and a chemical engineer may collaborate with analysts, safety specialists and manufacturing teams to solve the problems.

This is one reason professional Chemistry cannot be reduced to learning reaction names. The product has to meet specification repeatedly, using justified measurements and documented processes.

Worked example: yield does not prove purity

Imagine a fictional synthesis of compound X. The balanced theoretical calculation predicts that the chosen quantity of starting material could form 10.0 g of pure X. The student isolates 7.0 g of a solid material and reports a 70% isolated mass yield.

That 70% is not necessarily the yield of pure X. Suppose a suitable validated assay shows that the isolated material is 95.0% X by mass. Then the amount of X in the recovered material is approximately:

7.0 g × 0.950 = 6.65 g of X.

The pure-product recovery relative to the theoretical maximum is:

6.65 / 10.0 × 100% = 66.5%.

The number changes because the evidence changed. A serious chemist distinguishes recovered mass from measured purity and reports the calculation’s basis. Actual pharmaceutical quality assessment requires multiple specifications and validated procedures; one percentage does not make a batch suitable for treatment.

At upper Secondary level, this is an exercise in percentage yield and purity. At JC level, it is an exercise in the relationship between chemical calculations and analytical evidence. At university and in practice, it becomes an introduction to assay validation, traceability, process control and quality assurance.

Why clinical studies cannot be skipped

Now imagine a molecule works well in a cell-based experiment. It may be promising, but the experiment does not reveal the full balance of benefit and harm in human patients. Even if a biological mechanism is plausible, researchers must establish whether the intended medical outcome happens under appropriate conditions.

Clinical research evaluates outcomes in people under regulated protocols, ethical oversight and methods suited to the question. The design and strength of evidence vary, but investigators must address confounding, measurement, follow-up and potential adverse effects. Approval decisions also consider quality and manufacturing information. Monitoring continues after appropriate products enter use.

The FDA’s process summary is a useful starting point. In Singapore, refer to the HSA’s therapeutic products guidance for the local regulatory context.

This is a powerful science lesson because it links Chemistry to statistical thinking, Biology, ethics and public trust. Students learn to distinguish a mechanism, a measured effect, a clinical outcome and an authorised medical claim.

From a school laboratory to global medicine access

Science does not finish when a regulator approves a product. Supply reliability, storage, quality monitoring, affordability, access, public health and responsible use all matter. Some medicines require stringent temperature controls or complex production equipment; others face raw-material shortages or distribution challenges.

Different countries have different capacities, disease burdens and healthcare systems. The chemical identity of an active ingredient is essential, but getting an appropriate treatment safely to the person who needs it is a broader social and engineering problem.

If a teenager likes Chemistry because they want to improve human health, I encourage that ambition while expanding their view. The work may lead into medicinal Chemistry, pharmacy, pharmaceutical science, analytical testing, regulatory science, public health, chemical engineering, biotechnology, clinical research or another allied field. These are distinct pathways with different education and professional requirements.

Six scientific questions to ask about a claim for a new medicine

What was studied? Was the result from a computer model, a chemical assay, cells, an animal model or human clinical research?
What outcome was measured? A change in a biochemical marker may not be the same as a patient-centred health benefit.
How reliable is the method? Were controls, comparison groups, analytical checks and relevant uncertainties considered?
Who was represented? Findings in one population or study setting may not generalise to every person.
What harms were considered? An apparent benefit must be evaluated alongside important risks and limits.
Which authority reviewed the claim? Regulatory status matters, and jurisdictions do not have perfectly identical systems.

This checklist does not turn a Chemistry student into a clinician. It helps them recognise when evidence is incomplete and why a confident headline can overstate a result.

What changes from Secondary school to JC and university?

Secondary 1–2: precise foundations

Students should know elements, compounds, mixtures, particles, simple chemical changes, solutions and the logic of a fair test. I ask them to explain why a tablet containing an active ingredient is a formulated product, not necessarily a pure chemical substance.

Secondary 3–4: reactions and structures

Students develop bonding, organic functional groups, chemical equations, amounts of substances, rates and reaction conditions as applicable to their route. They learn to interpret a reaction pathway without assuming that any stated equation proves a usable medicine can be made.

JC H1/H2: models and calculations

JC learners can connect equilibria, reaction mechanisms, energetics, kinetics and experimental interpretation to real molecular behaviour. They should learn to state assumptions before interpreting data and distinguish a theoretical yield from verified chemical purity.

Polytechnic, university and professional work

More advanced training may involve spectroscopy, chromatography, statistics, microbiology, pharmacology, toxicology, regulatory systems, professional ethics and good laboratory practice. A person in the field needs not only to answer a question but to defend the method used to reach the answer.

I would never encourage choosing H1, H2 or H3 purely to look impressive. Instead, check your interests, strengths, school options and specific current course prerequisites. Our Chemistry roadmap from Secondary to university gives a longer view.

A four-week reading and reasoning exercise

I would keep this entirely research-based at home. There is no need to open capsules, test unknown substances, take medication for a learning exercise or follow online instructions for synthesising anything.

Week 1: choose a general medicine category in an official healthcare or regulator information page. Identify what an active ingredient is and which product information concerns formulation, route and safe use.

Week 2: read the FDA’s drug-development diagram. Write one sentence explaining why laboratory discovery, preclinical research and clinical evidence are not interchangeable.

Week 3: work through the fictional purity-and-yield example above, then change the assay purity to 80% and calculate the revised pure-product recovery: 7.0 × 0.80 = 5.6 g, which is 56% of the theoretical pure yield.

Week 4: write a 250-word explanation of why a promising molecular result might still fail to become a medicine. Include at least one chemistry reason, one evidence reason and one manufacturing or access issue.

Revisit the first answer after the fourth week. The goal is to see whether the learner can now distinguish scientific levels of explanation without hints.

When the student is stuck: a useful diagnostic

Some Secondary students struggle because molecules, ions and formulas are not yet secure. Others can balance equations but cannot distinguish structural formulas. At JC level, the difficulty might be organic reaction mechanisms, equilibrium assumptions, purification or interpreting practical evidence.

A suitable Chemistry tutor supporting a Hougang learner should diagnose which error is present. I would ask for a written explanation of one changed-case question rather than rely solely on the student’s confidence rating or a memorised model answer.

The strongest progress indicator is transfer: can the student use the same chemical principle in an unfamiliar situation and explain where the simplified model stops being adequate? That is a far more meaningful target than completing a particular number of worksheets.

A self-test with model responses

Question 1: two structures, one molecular formula

Do two molecules with the same molecular formula always have identical properties?

Answer: no. They may be isomers with different connectivity or spatial arrangement. Their physical and chemical properties, including possible biological interactions, can differ.

Question 2: strong binding

Does a candidate’s strong binding to one protein establish that it is an effective medicine?

Answer: no. Relevant biological effects, selectivity, exposure, toxicity, appropriate clinical outcomes and other evidence must be established. Binding is one part of a larger development process.

Question 3: recovery calculation

A theoretical yield is 20 g, while an isolated solid weighs 15 g and is 80% pure. What is the mass of pure product and the pure-product percentage recovery?

Answer: 15 × 0.80 = 12 g pure product; 12 / 20 × 100% = 60% recovery relative to the theoretical mass.

Question 4: one assay result

A chemical test detects an intended ingredient. Does that prove the entire batch meets clinical and quality requirements?

Answer: no. Identity is only one attribute. Relevant purity, impurity, stability, dose consistency, manufacturing and other validated quality requirements are separate questions.

Question 5: clinical news

A headline reports that a compound changed a marker in laboratory cells. May a student conclude that people should start taking it?

Answer: no. Results in cells cannot by themselves establish safety, effectiveness or appropriate use in people. Only suitably qualified healthcare professionals and authorised information should guide treatment decisions.

Questions parents often ask

Does medicinal chemistry require excellent Biology?

Biology can be very helpful, but the exact subject prerequisites depend on the intended degree and pathway. Chemistry, Mathematics and scientific communication are also important. Check current programme requirements rather than assume all medicine-related routes are the same.

Is drug discovery just organic Chemistry?

No. Organic synthesis may be central to some work, but analytical Chemistry, biochemistry, physical Chemistry, computation, statistics, engineering, clinical science and regulation all contribute.

Should my child memorise drug names to prepare for university?

Usually that is not an effective substitute for foundations. Learn chemical bonding, functional groups, quantitative reasoning, equilibria, experimental evidence and how to read reliable scientific information.

Do all natural products make safer medicines?

No. A substance’s origin does not establish safety or therapeutic benefit. Its properties, exposure, evidence and clinical context must be evaluated.

Can someone work in pharmaceutical science without being a doctor?

Yes. Many research, manufacturing, quality and regulatory roles are distinct from practising medicine. The specific educational and professional requirements vary.

Sources and further reading

Continue learning Chemistry

If a learner needs additional help, I would begin by reviewing an actual school question and correction to see whether the barrier is molecular structure, chemical calculations or evidence interpretation. Parents exploring individual learning support can arrange a consultation with eduKate Singapore.

Chemistry Hougang | How Medicines Work: Drug Discovery, Dosage and Molecular Design